Yunzhi XiangGuanghui WangBaoliang LiuHaotian ZhengQiang LiuGuoyuan MaJiajun Du
Our study highlights the significant role of gene signature in predicting the prognosis and immunotherapy efficacy of LUAD patients, and identifies TRIM28 as a potential biomarker for the treatment of LUAD.
Yupeng JiangBacha HammadHong HuangChenzi ZhangBing XiaoLinxia LiuQimi LiuHengxing LiangZhenyu ZhaoYawen Gao
Zuwei LiMinzhang GuoWanli LinPeiyuan Huang
Xueting CaoBoya WuYingzheng HouJing Chen
Qilong WangNannan SunMingzhi Zhang